STOCK TITAN

Vynleads (VYND) 10-Q Filings

VYND OTC

Here are the 10-Q quarterly reports from Vynleads Inc (VYND) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow VYND and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VYND filings page.

Rhea-AI Summary

Vynleads, Inc., a wellness technology company focused on metabolic health and an app-based diabetes support program, reported another loss-making quarter with no revenue for the three and six months ended June 30, 2026. For the six-month period, the company generated $0 revenue, incurred a net loss of $160,845 (vs. $138,051 in 2025), and used $91,439 of cash in operating activities.

The balance sheet is highly constrained: cash was $18,189, total assets $27,270, against current liabilities of $475,546, resulting in a working capital deficit of $448,276 and an accumulated deficit of $3,201,441. Notes payable totaled $230,349, including multiple unsecured notes, some noted as in default, and a small Paycheck Protection Program loan with forgiveness still pending. Stockholders’ deficit widened to $(448,276).

Management explicitly states there is substantial doubt about the company’s ability to continue as a going concern. The business has been funded primarily through debt, including $65,000 of new bridge financing in the first half of 2026, and currently has no committed financing facilities. Management estimates it needs approximately $5,500,000 of additional working capital over the next 12 months to pursue product development, marketing, infrastructure expansion and general operations.

Rhea-AI Summary

Vynleads, Inc. reported a Q1 2026 net loss of $96,956 on no revenue, continuing a history of losses and leaving an accumulated deficit of $3,137,552. Cash fell to $262 at March 31, 2026 against current liabilities of $421,730, creating a working capital deficit of $416,887 and prompting management to state there is substantial doubt about the company’s ability to continue as a going concern.

Operations were funded largely by related-party in‑kind services and notes payable, with interest expense of $1,986 in the quarter and multiple notes in default or pending forgiveness. Management estimates it needs about $5,500,000 of additional capital over the next 12 months to pursue growth plans and cover operating costs, and executed an additional $40,000 of notes shortly after quarter‑end.

Rhea-AI Summary

Vynleads, Inc. filed its quarterly report for the period ended September 30, 2025. The company reported revenue of $0 and a net loss of $58,069 for the quarter; the nine‑month net loss was $196,120. Management states there is substantial doubt about the company’s ability to continue as a going concern.

Liquidity remained tight: cash was $36,322 and total assets $40,753, against current liabilities of $366,738, resulting in a working capital deficit of $325,985. Notes payable totaled $130,309, and the company disclosed defaults on certain senior notes. Selling, general and administrative expense increased year over year, contributing to losses.

The company reported a material weakness in internal control over financial reporting. As of November 1, 2025, there were 18,327,364 common shares outstanding. Management indicates additional capital will be needed to fund operations and growth initiatives.